BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Caliper Life Sciences, Inc. (CALP) Announces CE IVD Mark for LabChip® Dx for Clinical Patient Sample Testing


7/26/2011 10:52:16 AM

HOPKINTON, Mass., July 26, 2011 /PRNewswire/ -- Caliper Life Sciences, Inc. (NASDAQ: CALP) announced today that its new, innovative LabChip® Dx instrument has achieved CE IVD registration in Europe. The LabChip Dx, a novel instrument based on Caliper's robust LabChip microfluidics technology, will now be marketed and sold in Europe with the CE IVD Mark under the European Directive on In Vitro Diagnostic Medical Devices. The LabChip Dx was developed in collaboration with Seegene, Inc., with whom Caliper announced a strategic partnership earlier this year.

"Under the CE IVD Mark, the LabChip Dx instrument is available for use with clinical patient samples in Europe, and we expect it will bring significant benefit to European clinical diagnostic laboratories by improving overall lab economics and reducing manual labor requirements," said Kevin Hrusovsky, President and CEO of Caliper Life Sciences. "The CE IVD Mark makes the LabChip Dx more attractive for European diagnostic labs and completes an important regulatory step for running tests from the Seeplex menu of diagnostic assays from Seegene."

"The LabChip Dx, launched in February of this year, has seen excellent market uptake," continued Mr. Hrusovsky. "To date, we have received orders for forty units from markets around the world. We believe the robustness and reliability of the LabChip Dx, as well as Caliper's service excellence, have proven to be attractive to our partners and customers."

The LabChip Dx system features diagnostic identification, scoring and reporting software. It is based on the same microfluidics technology that has become the standard electrophoretic separation platform in research, enabling high throughput, multiplexed, cost effective sample processing for discovery and validation of molecular and companion diagnostics. The platform can analyze large numbers of multiplex samples using minimal sample volume, provides automatic pipetting, and avoids the need to further purify or dilute diagnostic PCR products. The cost effective approach of Caliper's robust microfluidics platform explains its high rate of adoption among research laboratories around the world.

About Caliper Life Sciences

Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions.

The LabChip Dx utilizes Caliper's innovative microfluidics technology to perform reproducible, high-resolution, electrophoretic separations for analyzing multiplex PCR products. For additional information about Caliper's solutions for molecular and companion diagnostics, please visit www.caliperls.com.

Caliper and LabChip are registered trademarks of Caliper Life Sciences, Inc.

SOURCE Caliper Life Sciences, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES